Foresite Capital

Intellia Therapeutics

Cambridge

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Xaira Therapeutics

South San Francisco

an integrated biotechnology company driving advances in AI to transform how we treat disease.

Invivyd

New Haven

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Element Biosciences

San Diego

Element Biosciences is a life science company that focuses on developing innovative genetic analysis tools.

insitro

South San Francisco

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

CG Oncology

Dallas

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Keros Therapeutics

Lexington

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

DELFI Diagnostics

Palo Alto

Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.

Seaport Therapeutics

Boston

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

Sollis Health

New York

Sollis Health offers concierge medical centers that provide on-demand care for families, including same-day visits and virtual care options.

MyOme

California

MyOme uses whole-genome sequencing and state-of-the-art bioinformatics to analyze a single patient sample, delivering comprehensive, clinically actionable reports that translate genetic data into guidance for personalized lifestyle, prevent

REGENXBIO

Rockville

REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

Intarcia Therapeutics

Boston

We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking.